glp-1 weight loss drug news today weight-loss drugs may also curb alcohol cravings New Zepbound-Like GLP-1 Drug Leads

The study supports the utility of DSIP-CBBBP in developing therapies targeting neurotransmitter dysregulation and sleep disturbances, offering a promising avenue for future research in sleep-related treatments

Staber PB, Herling M, Bellido M, Jacobsen ED, Davids MS, Kadia TM, et al

These volumes are much easier to measure accurately, reducing the chance of dosing errors while keeping injection volumes manageable

Investigational peptides with genuine clinical-development programmes

tuberose methanolic root extract (PTME) as a potential herbal treatment on the liver homogenates of alloxan-induced diabetic rats, it was reported that PTME possessed an abundance of flavonoids and significantly reduced DPP-IV activity in a time-dependent manner from 16 DPP-IV activity in a time-dependent manner fromto 4 M/unit as compared with alloxan control (17.5 M/unit) within a period of 40 days, which proved that PTME was a promising candidate to cure DPP-IV-induced liver disorders (84)